Cargando…

Ceftobiprole for the treatment of pneumonia: a European perspective

Ceftobiprole, a new broad spectrum, parenteral cephalosporin, exhibits potent in vitro activity against a number of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae, and Gram-negative pathogens associated with hospital-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liapikou, Adamantia, Cillóniz, Catia, Torres, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547641/ https://www.ncbi.nlm.nih.gov/pubmed/26316697 http://dx.doi.org/10.2147/DDDT.S56616

Ejemplares similares

Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease
por: Crisafulli, Ernesto, et al.
Publicado: (2020)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2018)

Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
por: Torres, Antonio, et al.
Publicado: (2016)

Ceftobiprole Perspective: Current and Potential Future Indications
por: Lupia, Tommaso, et al.
Publicado: (2021)

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2019)

Safety and tolerability of ceftobiprole
por: Grau, Santiago
Publicado: (2019)

Ceftobiprole medocaril
por: Méndez, Raúl, et al.
Publicado: (2022)

Possible clinical indications of ceftobiprole
por: Barberán, José
Publicado: (2019)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019)

Mechanisms of action and antimicrobial activity of ceftobiprole
por: Morosini, María-Isabel, et al.
Publicado: (2019)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
por: Cillóniz, Catia, et al.
Publicado: (2018)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Ceftobiprole: a clinical view
por: Pérez-Crespo, Pedro María Martínez, et al.
Publicado: (2021)

Epidemiology, etiology, and risk factors of bacterial pneumonia
por: Torres, Antoni, et al.
Publicado: (2015)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Torres, Antoní, et al.
Publicado: (2023)

Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome
por: Ferrer, Miquel, et al.
Publicado: (2015)

Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients
por: Rubino, Christopher M., et al.
Publicado: (2021)

In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016–19)
por: Canton, Rafael, et al.
Publicado: (2022)

Aspiration pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Emerging agents to combat complicated and resistant infections: focus on ceftobiprole
por: Bustos, César, et al.
Publicado: (2010)

Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns
por: Cilloniz, Catia, et al.
Publicado: (2016)

Community-acquired pneumonia in critically ill very old patients: a growing problem
por: Cillóniz, Catia, et al.
Publicado: (2020)

Promoting the use of social networks in pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2020)

Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
por: Barbour, April, et al.
Publicado: (2010)

Antimicrobial Resistance Among Streptococcus pneumoniae
por: Cillóniz, Catia, et al.
Publicado: (2018)

Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series
por: Mahmoud, Ebrahim, et al.
Publicado: (2020)

Outpatient Management of COVID-19 Disease: A Holistic Patient-Centered Proposal Based on the Greek Experience
por: Liapikou, Adamantia, et al.
Publicado: (2021)

Predicting treatment failure in patients with community acquired pneumonia: a case-control study
por: Martin-Loeches, Ignacio, et al.
Publicado: (2014)

Streptococcus pneumoniae-associated pneumonia complicated by purulent pericarditis: case series
por: Cillóniz, Catia, et al.
Publicado: (2015)

Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials
por: Scheeren, Thomas W. L., et al.
Publicado: (2019)

Addendum: Cillóniz, C.; Dominedò, C.; Nicolini, A.; Torres, A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms 2019, 7, 49
por: Cillóniz, Catia, et al.
Publicado: (2019)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

2162. In Vitro Antimicrobial Activity of Ceftobiprole against Streptococcus pneumoniae Isolates from the United States (2016–2020)
por: Duncan, Leonard R, et al.
Publicado: (2023)

Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin”
por: Giuliano, Simone, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ht9nvu26gcbos9e8s67etdbqi